Christopher Taylor | VP, IR |
David Mauney | President |
Laurence Cooper | Chief Executive Officer |
Satyavrat Shukla | EVP and Chief Financial Officer |
Drew Deniger | Director of TCR Program |
David Novak | Raymond James |
Thomas Flaten | Lake Street Capital |
I-Eh Jen | Laidlaw |
Sean Lee | H.C. Wainwright |
Good morning, ladies and gentlemen, and welcome to the Ziopharm Oncology Second Quarter 2019 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr.